Karyotypic characteristics of borderline malignant tumors of the ovary: trisomy 12, trisomy 7, and r(1) as nonrandom features
- PMID: 8976364
- DOI: 10.1016/s0165-4608(96)00169-0
Karyotypic characteristics of borderline malignant tumors of the ovary: trisomy 12, trisomy 7, and r(1) as nonrandom features
Abstract
Clonal karyotypic abnormalities were detected in five of 14 cytogenetically analyzed borderline malignant ovarian tumors of clinical stages I-II. One mucinous and one seropapillary tumor had trisomy 7 and r(1)(p36q42) as the sole chromosome abnormality, respectively. Trisomy 12 was found in the remaining three cases. It was the only change in one mucinous and one serous tumor, whereas the third, a seropapillary borderline tumor, had the karyotype 49,XX,+5,+8, +12. These findings, especially when collated with those of previous reports on ovarian borderline tumor cytogenetics, indicate that +12 is the most consistent chromosomal aberration in this group of neoplasms and that also +7 and r(1) are nonrandom features. From the karyotypic point of view, benign ovarian tumors and well-differentiated carcinomas are similar to borderline ovarian tumors, with the possible exception that the former have no tendency to form r(1). Highly malignant carcinomas, on the other hand, are typically much more complex. Chromosome-level changes therefore cannot account for the putative phenotypic passage through the most innocuous tumor stages as epithelial ovarian neoplasms go from benign to fully malignant.
Similar articles
-
Trisomy 12 is a consistent chromosomal aberration in benign ovarian tumors.Genes Chromosomes Cancer. 1990 May;2(1):48-52. doi: 10.1002/gcc.2870020109. Genes Chromosomes Cancer. 1990. PMID: 2177641
-
Chromosome 6 abnormalities in ovarian surface epithelial tumors of borderline malignancy suggest a genetic continuum in the progression model of ovarian neoplasms.Clin Cancer Res. 2001 Nov;7(11):3404-9. Clin Cancer Res. 2001. PMID: 11705855
-
Numerical chromosomal aberrations in borderline, benign, and malignant epithelial tumors of the ovary: correlation with p53 protein overexpression and Ki-67.J Soc Gynecol Investig. 1997 Sep-Oct;4(5):262-4. J Soc Gynecol Investig. 1997. PMID: 9360232
-
Cytogenetic findings in invasive breast carcinomas with prognostically favourable histology: a less complex karyotypic pattern?Int J Cancer. 1998 Aug 21;79(4):361-4. doi: 10.1002/(sici)1097-0215(19980821)79:4<361::aid-ijc9>3.0.co;2-t. Int J Cancer. 1998. PMID: 9699527 Review.
-
Ovarian carcinomas: at least five different diseases with distinct histological features and molecular genetics.Hum Pathol. 2018 Oct;80:11-27. doi: 10.1016/j.humpath.2018.06.018. Epub 2018 Jun 23. Hum Pathol. 2018. PMID: 29944973 Review.
Cited by
-
Evaluation of the tyrosine kinase domain of the Met proto-oncogene in sporadic ovarian carcinomas*.Pathol Oncol Res. 1999;5(3):187-91. doi: 10.1053/paor.1999.0219. Pathol Oncol Res. 1999. PMID: 10491015
-
Gross genomic alterations differ between serous borderline tumors and serous adenocarcinomas--an image cytometric DNA ploidy analysis of 307 cases with histogenetic implications.Virchows Arch. 2009 Jun;454(6):677-83. doi: 10.1007/s00428-009-0778-y. Epub 2009 May 8. Virchows Arch. 2009. PMID: 19421773
-
Chromosome 3 anomalies investigated by genome wide SNP analysis of benign, low malignant potential and low grade ovarian serous tumours.PLoS One. 2011;6(12):e28250. doi: 10.1371/journal.pone.0028250. Epub 2011 Dec 6. PLoS One. 2011. PMID: 22163003 Free PMC article.
-
Genomic aberrations in borderline ovarian tumors.J Transl Med. 2010 Feb 26;8:21. doi: 10.1186/1479-5876-8-21. J Transl Med. 2010. PMID: 20184781 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical